Live Breaking News & Updates on Molecular Cancer Therapy Research Unit

Stay updated with breaking news from Molecular cancer therapy research unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Team presents promising results from first clinical trial of next-gen antibody in patients with advanced solid tumors

Initial data from the first phase 1 trial of the bispecific antibody FS222 demonstrate that it is a drug with a manageable safety profile and promising antitumour activity, especially in patients with metastatic cutaneous melanoma refractory to immunotherapy with anti-PD1 immune checkpoint inhibitors. ....

United States , Elena Garralda , Molecular Cancer Therapy Research Unit Uitm Caixaresearch , Molecular Cancer Therapy Research Unit ,

The first clinical trial of Omomyc against cancer proves its safety and anti-tumor activity

The results of the first phase of the clinical trial of Omomyc (OMO-103) showed that the new drug is safe and has anti-tumor activity. Thus, in some ....

Elena Garalda , Laura Soucek , Molecular Cancer Therapy Research Unit , Antitumor Therapies Modeling Group , Experimental Therapies Program , Therapies Modeling , Marie Eve Beaulieu ,